Last10K.com

Inventiva S.A. (IVA) SEC Filing 6-K Foreign Issuer Report for the period ending Monday, May 16, 2022

Inventiva S.A.

CIK: 1756594 Ticker: IVA

View differences made from one to another to evaluate Inventiva S.A.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Inventiva S.A..

Continue

Assess how Inventiva S.A.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Inventiva S.A.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Inventiva S.A. provided additional information to their SEC Filing as exhibits

Ticker: IVA
CIK: 1756594
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001171843-22-003734
Submitted to the SEC: Mon May 16 2022 4:33:39 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Monday, May 16, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/iva/0001171843-22-003734.htm